5 Recruiting Head and Neck Cancer Clinical Trials in Illinois
Explore active head and neck cancer research studies enrolling across Illinois. Verify eligibility and contact site coordinators.
📍 Find Near Me by DistanceBrowse by City
Recruiting Head and Neck Cancer Studies in Illinois
🟡 Not Yet Recruiting Phase2 💊 Investigational Drug / Biologic
RiMO-HNC-NEO1: Phase 2 Study of RiMO-301 and Hypofractionated Radiotherapy With Pembrolizumab for the Neoadjuvant Treatment of Resectable, Locally Advanced Head-Neck Cancer
📍 University of Illinois at Chicago — Chicago, Illinois
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
A Study Comparing Two Immunotherapy Options for Human Papillomavirus Positive HPV-Positive Head and Neck Cancer After Treatment
📍 The University of Chicago — Chicago, Illinois
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer
📍 University of Chicago Comprehensive Cancer Center — Chicago, Illinois
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Response-Adaptive Treatment in Untreated Locoregional HPV-Negative Head and Neck Cancer
📍 The University of Chicago — Chicago, Illinois
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer
📍 The University of Chicago — Chicago, Illinois
View Study & Checklist ➔